PacBio to Participate in Morgan Stanley Healthcare Conference

MENLO PARK, Calif., Sept. 03, 2026 /CourierPR/ -- PacBio, a leading developer of high-quality sequencing solutions, will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026, at 4:50 PM Eastern Time in New York City. Management from the company will discuss their latest advancements and insights into the field of genetic research.

The event will be live-streamed on PacBio’s investor page at investor.pacificbiosciences.com, allowing those unable to attend in person to follow along. A replay of the session will be available for at least 30 days following the conference.

PacBio, headquartered in Santa Clara, California, is dedicated to providing advanced sequencing technologies for a range of applications. Their HiFi long-read sequencing technology is designed to help scientists and clinical researchers tackle genetically complex problems. The company’s products and solutions are used in various fields, including human germline sequencing, plant and animal sciences, infectious disease and microbiology, and oncology.

It is important to note that PacBio products are intended for research use only and are not suitable for diagnostic procedures.